BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35363213)

  • 1. Efficacy and safety of rt-PA intravenous thrombolysis in patients with wake-up stroke: A meta-analysis.
    Liu H; Hu W; Zhang F; Gu W; Hong J; Chen J; Huang Y; Pan H
    Medicine (Baltimore); 2022 Feb; 101(7):e28914. PubMed ID: 35363213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis for Wake-Up Stroke Versus Non-Wake-Up Unwitnessed Stroke: EOS Individual Patient Data Meta-Analysis.
    Kamogawa N; Miwa K; Toyoda K; Jensen M; Inoue M; Yoshimura S; Fukuda-Doi M; Kitazono T; Boutitie F; Ma H; Ringleb P; Wu O; Schwamm LH; Warach S; Hacke W; Davis SM; Donnan GA; Gerloff C; Thomalla G; Koga M;
    Stroke; 2024 Apr; 55(4):895-904. PubMed ID: 38456303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic therapy for patients who wake-up with stroke.
    Barreto AD; Martin-Schild S; Hallevi H; Morales MM; Abraham AT; Gonzales NR; Illoh K; Grotta JC; Savitz SI
    Stroke; 2009 Mar; 40(3):827-32. PubMed ID: 19131657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic Treatment in Wake-Up Stroke: A Propensity Score-Matched Analysis of Treatment Effectiveness in the Norwegian Stroke Registry.
    Søyland MH; Tveiten A; Eltoft A; Øygarden H; Varmdal T; Indredavik B; Mathiesen EB
    J Am Heart Assoc; 2024 Feb; 13(3):e032309. PubMed ID: 38293909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C; Bai Q; Zhao Z; Zhang J
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese herbal injections combined with rt-PA intravenous thrombolysis for acute ischemic stroke: A systematic review and meta-analysis protocol.
    Wu J; Wang L; Dong X; Li Z; Wang K; Li L; Liu J
    Medicine (Baltimore); 2021 Mar; 100(10):e25004. PubMed ID: 33725879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy for wake-up stroke: A systematic review and meta-analysis.
    Mac Grory B; Saldanha IJ; Mistry EA; Stretz C; Poli S; Sykora M; Kellert L; Feil K; Shah S; McTaggart R; Riebau D; Yaghi S; Gaines K; Xian Y; Feng W; Schrag M
    Eur J Neurol; 2021 Jun; 28(6):2006-2016. PubMed ID: 33772987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
    Lei YS; Li H; Lei JY; Li SX; Li DF
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and effectiveness of early anti-platelet therapy after alteplase for acute ischemic stroke: A meta-analysis.
    Liu J; Hu X; Wang Y; Guan X; Chen J; Liu H
    J Clin Neurosci; 2021 Sep; 91():176-182. PubMed ID: 34373024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reperfusion therapy for minor stroke: A systematic review and meta-analysis.
    Lan L; Rong X; Li X; Zhang X; Pan J; Wang H; Shen Q; Peng Y
    Brain Behav; 2019 Oct; 9(10):e01398. PubMed ID: 31532082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a new modified intravenous recombinant tissue plasminogen activator (rt-PA) regimen in Chinese patients with acute ischemic stroke: A descriptive retrospective cohort study with subgroup-analysis of different rt-PA dose.
    Luo Y; Li J; Huang L; Liu X; Zhang B; Lin J; Jiang A; Zhao J
    J Clin Neurosci; 2022 Jul; 101():244-251. PubMed ID: 35653882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed tomography perfusion-based thrombolysis in wake-up stroke.
    Morelli N; Rota E; Immovilli P; Cosottini M; Giorgi-Pierfranceschi M; Magnacavallo A; Michieletti E; Morelli J; Guidetti D
    Intern Emerg Med; 2015 Dec; 10(8):977-84. PubMed ID: 26370239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.
    Pancioli AM; Adeoye O; Schmit PA; Khoury J; Levine SR; Tomsick TA; Sucharew H; Brooks CE; Crocco TJ; Gutmann L; Hemmen TM; Kasner SE; Kleindorfer D; Knight WA; Martini S; McKinney JS; Meurer WJ; Meyer BC; Schneider A; Scott PA; Starkman S; Warach S; Broderick JP;
    Stroke; 2013 Sep; 44(9):2381-7. PubMed ID: 23887841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
    Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y;
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein level is associated with hemorrhage transformation after ischemic stroke treatment with intravenous thrombolysis: A systematic review and meta-analysis.
    Zhang W; Li W; Tian R; Cao L
    J Clin Neurosci; 2022 Dec; 106():122-127. PubMed ID: 36283344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-contrast head CT-based thrombolysis for wake-up/unknown onset stroke is safe: A single-center study and meta-analysis.
    Zha AM; Kamal H; Jeevarajan JA; Arevalo O; Zhu L; Ankrom CM; Bonfante-Mejia EE; Cossey TD; Wu TC; Barreto AD; Grotta JC; Jagolino-Cole AL
    Int J Stroke; 2022 Mar; 17(3):354-361. PubMed ID: 33724081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.